News
Our work in News
-
Q&A with USC School of Pharmacy PhD Candidate Sang Cho
Meet Sang Cho, a USC School of Pharmacy PhD candidate in Health Economics, who served as business analyst on a USC Viterbi School of Engineering team that won first place in USC’s Maseeh Entrepreneurship Prize Competition.
-
Schaeffer Center Panel Divides Over Prospect of Medicare Drug Price Negotiation
The debate is increasingly focused on the tradeoff between innovation and access.
-
Valuing Cures Still Elusive According to Policymakers, Experts at DC Conference
Experts discussed the tensions of ensuring access for drugs while maintaining incentives for innovative cures at the conference.
-
Sood’s Health Research Cited in 2017 Economic Report of the President
The report is the final overview of the nation’s economic progress offered by the Obama administration.
-
Schaeffer Center Faculty Gives First in Series of Presentations on State-level Mental Health Care Coverage and Access
Seth Seabury provided analysis of how states can make mental health resources more accessible and where there is currently need.
Categorized in -
USC to Identify Best Approaches for Delivering Palliative Care Outside of Hospitals
Study provides rare opportunity to impact development and adoption of a health care service as it is starting to spread nationally, say researchers.
-
Poster Commitments Make an Impact on Antibiotic Prescribing
Study authors assist states and clinicians across the country to implement intervention.
-
Experts Call for Better Coordination to Boost End-of-Life Care in California
A fragmented health system and perverse financial incentives are major barriers to getting patients the care they need and desire.
-
New Grant Will Advance Study of Long-Term Interventions on Type 2 Diabetes
The $2.58 million grant is from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Categorized in -
Measuring Value in Clinical Trials: Patient Preference Doesn’t Equal Average Survival
Though clinical trials most often rely on average survival rates as measures of value, these are not synonymous indicators. New research by the Schaeffer Center finds additional factors may weigh in patient’s treatment choice.